Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Nutr ; 146(10): 2117-2123, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27558580

RESUMEN

BACKGROUND: Portion size is an important driver of larger meals. However, effects on food choice remain unclear. OBJECTIVE: Our aim was to identify how portion size influences the effect of palatability and expected satiety on choice. METHODS: In Study 1, adult participants (n = 24, 87.5% women) evaluated the palatability and expected satiety of 5 lunchtime meals and ranked them in order of preference. Separate ranks were elicited for equicaloric portions from 100 to 800 kcal (100-kcal steps). In Study 2, adult participants (n = 24, 75% women) evaluated 9 meals and ranked 100-600 kcal portions in 3 contexts (scenarios), believing that 1) the next meal would be at 1900, 2) they would receive only a bite of one food, and 3) a favorite dish would be offered immediately afterwards. Regression analysis was used to quantify predictors of choice. RESULTS: In Study 1, the extent to which expected satiety and palatability predicted choice was highly dependent on portion size (P < 0.001). With smaller portions, expected satiety was a positive predictor, playing a role equal to palatability (100-kcal portions: expected satiety, ß: 0.42; palatability, ß: 0.46). With larger portions, palatability was a strong predictor (600-kcal portions: ß: 0.53), and expected satiety was a poor or negative predictor (600-kcal portions: ß: -0.42). In Study 2, this pattern was moderated by context (P = 0.024). Results from scenario 1 replicated Study 1. However, expected satiety was a poor predictor in both scenario 2 (expected satiety was irrelevant) and scenario 3 (satiety was guaranteed), and palatability was the primary driver of choice across all portions. CONCLUSIONS: In adults, expected satiety influences food choice, but only when small equicaloric portions are compared. Larger portions not only promote the consumption of larger meals, but they encourage the adoption of food choice strategies motivated solely by palatability.


Asunto(s)
Conducta de Elección , Preferencias Alimentarias , Tamaño de la Porción , Adolescente , Adulto , Índice de Masa Corporal , Ingestión de Energía , Femenino , Humanos , Modelos Lineales , Almuerzo , Masculino , Saciedad , Encuestas y Cuestionarios , Adulto Joven
2.
Biochemistry ; 54(10): 1918-29, 2015 Mar 17.
Artículo en Inglés | MEDLINE | ID: mdl-25707433

RESUMEN

Platelet derived growth factor-BB (PDGF-BB) is an important mitogen and cell survival factor during development. PDGF-BB binds PDGF receptor-ß (PDGFRß) to trigger receptor dimerization and tyrosine kinase activation. We present the pharmacological and biophysical characterization of a blocking PDGF-BB monoclonal antibody, MOR8457, and contrast this to PDGFRß. MOR8457 binds to PDGF-BB with high affinity and selectivity, and prevents PDGF-BB induced cell proliferation competitively and with high potency. The structural characterization of the MOR8457-PDGF-BB complex indicates that MOR8457 binds with a 2:1 stoichiometry, but that binding of a single MOR8457 moiety is sufficient to prevent binding to PDGFRß. Comparison of the MOR8457-PDGF-BB structure with that of the PDGFRß-PDGF-BB complex suggested the potential reason for this was a substantial bending and twisting of PDGF-BB in the MOR8457 structure, relative to the structures of PDGF-BB alone, bound to a PDGF-BB aptamer or PDGFRß, which makes it nonpermissive for PDGFRß binding. These biochemical and structural data offer insights into the permissive structure of PDGF-BB needed for agonism as well as strategies for developing specific PDGF ligand antagonists.


Asunto(s)
Anticuerpos Monoclonales/química , Anticuerpos Neutralizantes/química , Proteínas Proto-Oncogénicas c-sis/antagonistas & inhibidores , Anticuerpos Monoclonales/genética , Anticuerpos Monoclonales/metabolismo , Anticuerpos Monoclonales/farmacología , Anticuerpos Neutralizantes/genética , Anticuerpos Neutralizantes/farmacología , Aptámeros de Péptidos/química , Aptámeros de Péptidos/genética , Aptámeros de Péptidos/metabolismo , Aptámeros de Péptidos/farmacología , Becaplermina , Sitios de Unión de Anticuerpos , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Humanos , Proteínas Proto-Oncogénicas c-sis/química , Proteínas Proto-Oncogénicas c-sis/metabolismo , Receptor beta de Factor de Crecimiento Derivado de Plaquetas
3.
Handb Clin Neurol ; 154: 45-58, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29903451

RESUMEN

In this chapter, we compare current understanding of the anatomy and functional compartmentation of the human cerebellum with detailed knowledge in nonhuman species. The anatomy of the cerebellum is highly conserved across mammals and comparison of functional data suggests that similar principles of organization also hold true for somatotopy. In particular, there is a dual representation of the limbs in the cerebellar cortex in rat, ferret, cat, monkey, and human. In animals, a key organizing principle of the cerebellum is its division into a series of longitudinally oriented olivocorticonuclear modules that are narrow in the mediolateral axis but extend across multiple cerebellar lobules in the rostrocaudal plane. This contrasts with existing understanding of the human cerebellum that suggests that functional compartmentation is organized mainly at the level of different lobes and lobules. However, advances in spatial resolution of imaging techniques mean we are now able to start to examine whether a longitudinal modular organization is also present within the human cerebellum. This has implications for the diagnosis and future treatment of clinical disorders that involve the cerebellum, since it is possible that variations in symptomatology may relate to this finer grain localization.


Asunto(s)
Enfermedades Cerebelosas/patología , Cerebelo/anatomía & histología , Vías Nerviosas/anatomía & histología , Animales , Enfermedades Cerebelosas/fisiopatología , Humanos , Red Nerviosa/citología , Red Nerviosa/fisiología , Vías Nerviosas/fisiología
4.
J Med Chem ; 53(16): 6122-8, 2010 Aug 26.
Artículo en Inglés | MEDLINE | ID: mdl-20666458

RESUMEN

Acidic mammalian chitinase (AMCase) is a member of the glycosyl hydrolase 18 family (EC 3.2.1.14) that has been implicated in the pathophysiology of allergic airway disease such as asthma. Small molecule inhibitors of AMCase were identified using a combination of high-throughput screening, fragment screening, and virtual screening techniques and characterized by enzyme inhibition and NMR and Biacore binding experiments. X-ray structures of the inhibitors in complex with AMCase revealed that the larger more potent HTS hits, e.g. 5-(4-(2-(4-bromophenoxy)ethyl)piperazine-1-yl)-1H-1,2,4-triazol-3-amine 1, spanned from the active site pocket to a hydrophobic pocket. Smaller fragments identified by FBS occupy both these pockets independently and suggest potential strategies for linking fragments. Compound 1 is a 200 nM AMCase inhibitor which reduced AMCase enzymatic activity in the bronchoalveolar lavage fluid in allergen-challenged mice after oral dosing.


Asunto(s)
Quitinasas/antagonistas & inhibidores , Modelos Moleculares , Piperazinas/síntesis química , Triazoles/síntesis química , Alérgenos/inmunología , Animales , Líquido del Lavado Bronquioalveolar , Dominio Catalítico , Cristalografía por Rayos X , Femenino , Interacciones Hidrofóbicas e Hidrofílicas , Espectroscopía de Resonancia Magnética , Ratones , Ratones Endogámicos C57BL , Piperazinas/química , Piperazinas/farmacología , Unión Proteica , Hipersensibilidad Respiratoria/tratamiento farmacológico , Hipersensibilidad Respiratoria/enzimología , Hipersensibilidad Respiratoria/inmunología , Relación Estructura-Actividad , Resonancia por Plasmón de Superficie , Triazoles/química , Triazoles/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA